Paul A Laviolette bought PLSE once, on May 11, 2026

Paul A. LaViolette

Paul A. LaViolette is Co-Chairman and Chief Executive Officer of Pulse Biosciences (NASDAQ: PLSE)( He is also Managing Partner at SV Health Investors, a leading life sciences growth equity and venture capital investor, where he joined as Venture Partner in 2009, became Partner in 2011, and was promoted to Managing Partner & COO in 2014, heading medical device investments( LaViolette serves on the boards of Edwards Lifesciences Corporation, Vibrato Medical, Inc., the Medical Device Manufacturers Association (past chairman), and chairs the Innovation Growth Board for Mass General Brigham(

With over 44 years in the medical device industry, LaViolette spent 15 years at Boston Scientific Corporation, rising to Chief Operating Officer and holding roles such as Group President of Cardiovascular, President of Cardiology, Group President of Endosurgery, and President International, during which revenues grew over 20 times while integrating two dozen acquisitions( Previously, he held marketing and general management positions at CR Bard (including President of Cardiology) and Kendall (Covidien/Medtronic)( He holds a BA in Psychology from Fairfield University (1979) and an MBA from Boston College (1981)(

Written by Perplexity from public sources.